the effects of fetal exposure to spironolactone ( spl ) , an aldosterone antagonist with weak antiandrogen and gestagen properties , upon the pituitary-gonadal axis were studied in the offspring of rats that had been treated daily from gestation day 14 to day 20 with 10 or 20 mg spl or the solvent vehicle ( for controls ) .
C0032961
gestation
C0037982
spl